Tian'an Technology (TANAF) Liabilities and Shareholders Equity (2022 - 2025)
Tian'an Technology's (TANAF) quarterly Liabilities and Shareholders Equity came in at $583873.0 in Q4 2025, down 43.07% year-on-year from $1.0 million in Q4 2024, and down 23.86% quarter-over-quarter from $766794.0 in Q2 2025.
Tian'an Technology (TANAF) Liabilities and Shareholders Equity (2022 - 2025) Analysis & Trends
Tian'an Technology has disclosed Liabilities and Shareholders Equity across 4 years of filings, most recently posting $583873.0 for Q4 2025.
- Liabilities and Shareholders Equity for Q4 2025 came in at $583873.0, down 43.07% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.5 million (up 55.02% YoY), and the FY2025 annual result was $583873.0, down 43.07% from the prior year.
- Liabilities and Shareholders Equity came in at $583873.0 for Q4 2025 at Tian'an Technology, down from $766794.0 in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.0 million in Q4 2024 to a low of $74702.0 in Q4 2022.
- The 4-year median for Liabilities and Shareholders Equity is $280498.0 (2023), against an average of $435460.4.
- Peak annual rise in Liabilities and Shareholders Equity reached 478.7% in 2024, while the deepest fall reached 50.28% in 2024.
- Tian'an Technology's Liabilities and Shareholders Equity stood at $74702.0 in 2022, then surged by 137.25% to $177233.0 in 2023, then soared by 478.7% to $1.0 million in 2024, then plunged by 43.07% to $583873.0 in 2025.
- The last three Liabilities and Shareholders Equity figures came in at $583873.0 (Q4 2025), $766794.0 (Q2 2025), and $1.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Tian'an Technology | - | - | - | 583,873.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 583,873.00 |
| Jun 30, 2025 | 766,794.00 |
| Dec 31, 2024 | 1.03 Mn |
| Jun 30, 2024 | 139,467.00 |
| Dec 31, 2023 | 177,233.00 |
| Jun 30, 2023 | 280,498.00 |
| Dec 31, 2022 | 74,702.00 |